Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.35
+0.81 (17.84%)
At close: Jun 26, 2026, 4:00 PM EDT
5.40
+0.05 (0.93%)
After-hours: Jun 26, 2026, 7:17 PM EDT
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $508.24 million as of June 26, 2026. Its market cap has increased by 551.90% in one year.
Market Cap
508.24M
Enterprise Value
282.64M
1-Year Change
551.90%
Ranking
Category
Stock Price
$5.35
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $508.24M, an increase of 203.74%. That is a compound annual growth rate of 25.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 508.24M | 49.16% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
| Sep 3, 2021 | 167.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 528.60M |
| Rezolute | 526.51M |
| Prothena Corporation | 524.58M |
| Arvinas | 516.17M |
| Forte Biosciences | 513.88M |
| Kyverna Therapeutics | 513.11M |
| Ocugen | 507.78M |
| Neurogene | 506.13M |